XML 29 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Additional Paid in Capital.
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid in Capital.
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Total
Beginning balance at Dec. 31, 2020   $ 17,125   $ 90,237     $ 212,163   $ 10,638     $ 330,163
Net income             52,681         52,681
Other comprehensive income (loss)                 (14,893)     (14,893)
Common stock repurchased   (18)   (348)     (346)         (712)
Common stock dividends             (10,931)         (10,931)
Share-based compensation expense   9   3,086               3,095
Vesting of restricted stock   97   (97)                
Ending balance at Dec. 31, 2021   17,213   92,878     253,567   (4,255)     359,403
Net income             40,005         40,005
Other comprehensive income (loss)                 (94,386)     (94,386)
Common stock repurchased   (26)   (712)               (738)
Common stock dividends             (13,146)         (13,146)
Stock issuance from the acquisition of Metro Phoenix Bank   2,681   61,149               63,830
Share-based compensation expense   10   1,894               1,904
Vesting of restricted stock   114   (114)                
Ending balance at Dec. 31, 2022 $ 19,992 19,992 $ 155,095 155,095 $ (4,452) $ 275,974 280,426 $ (98,641) (98,641) $ (4,452) $ 352,420 356,872
Net income             11,696         11,696
Other comprehensive income (loss)                 24,986     24,986
Common stock repurchased   (375)   (6,263)               (6,638)
Common stock dividends             (14,965)         (14,965)
Share-based compensation expense   18   1,610               1,628
Vesting of restricted stock   99   (99)                
Ending balance at Dec. 31, 2023   $ 19,734   $ 150,343     $ 272,705   $ (73,655)     $ 369,127